sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised - Wikidata - awgldk - TriplyDB

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised

http://www.wikidata.org/entity/Q37726033

about

sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research The core mechanism of dry eye disease is inflammation.Surfactant protein D contributes to ocular defense against Pseudomonas aeruginosa in a murine model of dry eye disease.Oleanolic acid controls allergic and inflammatory responses in experimental allergic conjunctivitis Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.Dry eye disease and microbial keratitis: is there a connection?ω-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye.Change in prostaglandin expression levels and synthesizing activities in dry eye disease.Dry eye disease as an inflammatory disorder.The neurobiology of lipid metabolism in autism spectrum disorders.TFOS DEWS II Tear Film Report.Proteomic analysis of human lacrimal and tear fluid in dry eye disease.Secretory phospholipase A2 in dromedary tears: a host defense against staphylococci and other gram-positive bacteria.

P2860

Q24635932-63114350-AE2B-4947-818F-1020ED0DD682 Q28393435-AD067616-CB29-4FC8-A6E4-A014B72656F0 Q33735876-2FE352CD-CEE0-43ED-97D2-65AA6B59365A Q33756582-87032D41-8A95-4493-B057-570C97710FC4 Q34510429-A67C76E5-6029-46FD-9B89-90DA172DAC41 Q34770248-92D0D7E7-6EBC-407E-BCCA-5AFCA9BA25C9 Q35139177-AAF33327-5F2C-4822-B7D2-4DEFF4B8DFEC Q35560971-E9337EE3-206C-49B4-B798-7F4551B40075 Q36099684-D28F92A2-1624-411A-AF41-1552892FB52A Q36799601-62C2B233-49F3-4FFC-ACA1-D8BF6E7D6F17 Q36872931-6E76BA76-0276-4386-A3D9-2E97E739AA82 Q36945904-825162A4-0B26-4E87-BAA3-CBDAFBCE7265 Q37756166-3120CE9D-C879-4886-889B-E89808DC0017 Q37846445-73575477-049B-40E7-8FF2-0A0E7E1688A6 Q38652990-38DFCD63-7CDE-42A2-A936-B4B0C4D5CC40 Q42657016-F987881E-B4FF-4FB8-9701-372E37C2A14F Q45282586-94D04616-C0F9-4F4C-8471-4C7F888D5A26

P2860

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised

http://www.wikidata.org/entity/Q37726033

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised

@en

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised.

@nl

type

label

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised

@en

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised.

@nl

prefLabel

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised

@en

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised.

@nl

P1433

Q37726033-D8E6CCAA-E1EE-4BD0-B04D-05EC618CA1A4

P1476

Q37726033-7041D1C1-5CD5-488D-AC84-58BA63D7992E

P2093

Q37726033-0114B930-9A9E-40F3-9196-69F066E395D0

Q37726033-059ABC19-C124-4DF9-8835-7A5E1B5FE99F

Q37726033-249A4B5B-9FE5-4494-9415-81E4C428C6C9

Q37726033-2AD23D8B-519E-4A21-9632-8233AC1DA4ED

Q37726033-6D0868E1-C767-4813-8BCA-9F7AFA15BBA0

Q37726033-7466AB2D-D677-49FE-A29D-8DE5CFEB9F03

P2860

Q37726033-07D81FEB-2085-42EE-8E87-F723D6E3B69D

Q37726033-08645E9F-E2D5-4B94-AD6A-3B1FC8653434

Q37726033-164ACF17-E263-4988-B27B-1D0ADBF79511

Q37726033-18608C5A-0BD4-491E-8F51-1236245395CC

Q37726033-18ED6DC4-CFBA-4E26-BB24-787179D482F7

Q37726033-1DFDFC05-C9D3-4891-BFE1-B89A51342785

Q37726033-2536CB4D-416B-42E4-909E-958443B59EFE

Q37726033-2A64F203-9F34-49DC-B942-3A06A061BC8F

Q37726033-2DC9134B-3B1B-4F63-9804-CEEC5E869983

Q37726033-419EB054-54A3-4947-A88D-419685E92FE4

P304

Q37726033-477FC224-B000-4F6D-A518-B687554229C8

P31

Q37726033-1DFBE09D-8AF2-48CB-9354-C063872983F8

P356

Q37726033-115B9D21-7644-4FCE-8139-AB23ABE28316

P433

Q37726033-5411A6DD-A9F5-49C2-A365-D2C73F8A6156

P478

Q37726033-6DF21CEA-F0E1-4F56-BBC2-6AE391A81FDD

P577

Q37726033-7E0582B5-942B-44E6-BA6C-8D63CAFD7F4F

P5875

Q37726033-CEB65B3D-62AC-450F-BB5A-3A6538385CD3

P698

Q37726033-CC81A860-A671-43D2-B803-BB009A05109E

P921

Q37726033-12A415A1-2B01-49B0-8040-3CF5BB826771

P932

Q37726033-18B59D9C-3AA6-4B32-B56A-2ACEAFCB5626

P356

J.EXER.2008.11.035

P1433

Experimental Eye Research

P1476

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised

@en

P2093

Dongmei Chen

http://www.w3.org/2001/XMLSchema#string

J Mario Wolosin

http://www.w3.org/2001/XMLSchema#string

Penny Asbell

http://www.w3.org/2001/XMLSchema#string

Seth Epstein

http://www.w3.org/2001/XMLSchema#string

Xiaohong Li

http://www.w3.org/2001/XMLSchema#string

Yi Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.

Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca

International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes

Diversity of group types, regulation, and function of phospholipase A2

Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix

Trehalose protects corneal epithelial cells from death by drying

Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2.

Interaction of low molecular weight group IIA phospholipase A2 with apoptotic human T cells: role of heparan sulfate proteoglycans.

Group IIA phospholipase A(2) content in tears of patients having photorefractive keratectomy.

Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.

P304

880-888

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXER.2008.11.035

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23713350

http://www.w3.org/2001/XMLSchema#string

P698

19116146

http://www.w3.org/2001/XMLSchema#string

P921

P932

4001256

http://www.w3.org/2001/XMLSchema#string